Development of Inhalable Nanostructured Lipid Carriers for Ciprofloxacin for Noncystic Fibrosis Bronchiectasis Treatment

Development of Inhalable Nanostructured Lipid Carriers for Ciprofloxacin for Noncystic Fibrosis Bronchiectasis Treatment

Alanood S Almurshedi, 1,* Hessah A Aljunaidel, 2 Bushra Alquadeib, 1 Basmah N Aldosari, 1,* Iman M Alfaqiah, 1 Salma S Almarshidy, 1 Eram KD Eltahir, 1 Amany Z Mohamoud 1 1Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia; 2Drug Regulatory Affairs, Novart...

Full description

Bibliographic Details
Main Authors: Almurshedi AS, Aljunaidel HA, Alquadeib B, Aldosari BN, Alfagih IM, Almarshidy SS, Eltahir EKD, Mohamoud AZ
Format: Article
Language:English
Published: Dove Medical Press 2021-03-01
Series:International Journal of Nanomedicine
Subjects:
ciprofloxacin
ncfb
nlcs
ncmps
dpi
aerosolization.
Online Access:https://www.dovepress.com/development-of-inhalable-nanostructured-lipid-carriers-for-ciprofloxac-peer-reviewed-article-IJN

Internet

https://www.dovepress.com/development-of-inhalable-nanostructured-lipid-carriers-for-ciprofloxac-peer-reviewed-article-IJN

Similar Items